13 results found.

Hypoglycemia Clinical Trial using G-Pen Mini™ (glucagon injection)

Xeris Pharmaceuticals - Recruiting 18 years to 30 years.
- A Randomized, Phase 2a, Blinded, 3-Way Crossover Dose-Ranging Study With G-Pen Mini™ (Glucagon Injection) to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Type 1 Diabetes Mellitus (T1DM).
G-Pen Mini™ (glucagon injection)

Prader Willi Syndrome, or Hypoglycemia Clinical Trial using Infants with Prader-Willi Syndrome

University of Florida - Recruiting 2 Months to 12 Months.
- Hypoglycemia in Prader-Willi Syndrome: A Prospective Study.
Infants with Prader-Willi Syndrome

Critical Illness, Hyperglycemia, or Hypoglycemia Clinical Trial using LOGIC-Insulin algorithm; Paper protocol

Katholieke Universiteit Leuven - Recruiting 18 years or older.
- LOGIC-Insulin Computerized Algorithm-guided Versus Nurse-directed Blood Glucose Control in Critically Ill Patients: the LOGIC-2 Multicentre Randomized Controlled Trial.
LOGIC-Insulin algorithm; Paper protocol

Type 1 Diabetes, or Hypoglycemia Unawareness Clinical Trial using Naltrexone

University of Minnesota - Clinical and Translational Science Institute - Recruiting 18 years to 65 years.
- Study of the Effect of Naltrexone on Cerebral Blood Flow and Hypoglycemia in Type 1 Diabetes Mellitus.
Naltrexone

Type 1 Diabetes, or Hypoglycemia Unawareness Clinical Trial using somatostatin

University of Minnesota - Clinical and Translational Science Institute - Recruiting 18 years to 65 years.
- Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness.
somatostatin

Type 2 Diabetes Clinical Trial using Glycemic clamping

Medical College of Wisconsin - Recruiting 21 years or older.
- Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans.
Glycemic clamping

Hypoglycemia Clinical Trial using Norepinephrine Transporter (NET) ligand

Yale University - Recruiting 18 years to 55 years.
- Evaluation of the Effect of Hypoglycemia on the Noradrenergic System With PET and a Highly Selective Norepinephrine Transporter Ligand.
Norepinephrine Transporter (NET) ligand

Type 1 Diabetes Clinical Trial using Algorithm ON

Stanford University - Recruiting 8 years to 25 years.
- .
Algorithm ON

Hypoglycemia, or Insulinoma Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 10 years or older.
- Fasting Hypoglycemia: Diagnosis and Treatment.

Diabetes Mellitus, Type 1, or Diabetes Mellitus, Type 2 Clinical Trial using Intranasal Glucagon; Glucagon

T1D Exchange Clinic Network Coordinating Center - Recruiting 18 years to 64 years.
- Efficacy and Safety of Intranasal Glucagon for Treatment of Insulin Induced Hypoglycemia in Adults With Diabetes.
Intranasal Glucagon; Glucagon

Hyperinsulinemic Hypoglycemia Clinical Trial using high carbohydrate test meal; high carbohydrate test meal after pre-treatment with rapid acting aspart insulin; high fructose , low glucose test meal with carbohydrate and caloric content similar to the control meal

University of Minnesota - Clinical and Translational Science Institute - Recruiting 21 years or older.
- Prevention of Hypoglycemia in Patients With Post-Gastric Bypass Hyperinsulinemic Hypoglycemia.
high carbohydrate test meal; high carbohydrate test meal after pre-treatment with rapid acting aspart insulin; high fructose , low glucose test meal with carbohydrate and caloric content similar to the control meal

Obesity With Complications, Morbid Obesity, Reactive Hypoglycemia Clinical Trial using Gastric Bypass; Sleeve Gastrectomy

Catholic University of the Sacred Heart - Recruiting 25 years to 65 years.
- RANDOMIZED CLINICAL STUDY COMPARING THE EFFECT OF ROUX-en-Y GASTRIC BYPASS AND SLEEVE GASTRECTOMY ON REACTIVE HYPOGLYCEMIA.
Gastric Bypass; Sleeve Gastrectomy

Post Bariatric Surgery, or Hypoglycemia Clinical Trial using Exendin-(9-39); Atropine; GLP-1 and GIP

University of Cincinnati - Recruiting 18 years to 65 years.
- Hormonal and Neural Control of Insulin Secretion Following Gastric Bypass Surgery.
Exendin-(9-39); Atropine; GLP-1 and GIP